Taryn Ambrosi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Taryn Ambrosi has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Giulietta Valuri
The University of Western Australia
3 shared publications - Patsy Di Prinzio
Neuropsychiatric Epidemiology Research Unit, School of Population and Global Health, The University of Western Australia, Perth, Australia
3 shared publications - Vera Anne Morgan
Neuropsychiatric Epidemiology Research Unit, School of Population and Global Health, The University of Western Australia, Crawley, Australia
3 shared publications Assen Jablensky
Centre for Clinical Research in Neuropsychiatry, Division of Psychiatry, Medical School, The University of Western Australia, Perth, WA, Australia
2 shared publications- Assen Jablensky
University of Western Australia
2 shared publications Maxine Croft
Neuropsychiatric Epidemiology Research Unit, School of Population and Global Health, The University of Western Australia, Perth, Australia
2 shared publications
Latest Publications
- 17 November 2025
- Published by CSIRO Publishing in Brain Impairment
- Vol. 26 (4)
Rehabilitation service provision and outcomes for children with stroke in Victoria and Western Australia in the pre-implementation era of clinical practice guidelines
Objective: This study described the rehabilitation services accessed by children with stroke following acute admission to two Australian paediatric tertiary hospitals prior to the implementation of clinical practice guidelines. It also evaluated quality-of-care indicators for inpatient rehabilitation within these two settings. Methods: Data were obtained from electronic medical records between 2014 and 2020. Quality-of-care was evaluated by comparing documented clinical care during that period with quality-of-care indicators for childhood stroke rehabilitation. Results: A total of 129 children (56% acute arterial ischaemic) with newly diagnosed stroke were identified (83 from Victoria, 46 from Western Australia). Of those, 45 in Victoria and 27 in Western Australia required inpatient rehabilitation. Children received high-quality inpatient rehabilitation care across both hospital settings, with the application of validated outcome measures and provision of rehabilitation care plans. Areas for improvement included greater involvement of families in the rehabilitation process, particularly with respect to the provision of regular family meetings to facilitate engagement. Conclusion: Although most children with stroke received high-quality care when compared against clinical practice guidelines, the findings highlight the importance of ongoing evaluation and continuous improvement in service provision, and the benefits of benchmarking the quality of current service provision against best practice treatment approaches recommended by consensus-based guidelines.
- 17 November 2025
- Published by CSIRO Publishing in Brain Impairment
- Vol. 26 (4)
Rehabilitation service provision and outcomes for children with stroke in Victoria and Western Australia in the pre-implementation era of clinical practice guidelines
Objective: This study described the rehabilitation services accessed by children with stroke following acute admission to two Australian paediatric tertiary hospitals prior to the implementation of clinical practice guidelines. It also evaluated quality-of-care indicators for inpatient rehabilitation within these two settings. Methods: Data were obtained from electronic medical records between 2014 and 2020. Quality-of-care was evaluated by comparing documented clinical care during that period with quality-of-care indicators for childhood stroke rehabilitation. Results: A total of 129 children (56% acute arterial ischaemic) with newly diagnosed stroke were identified (83 from Victoria, 46 from Western Australia). Of those, 45 in Victoria and 27 in Western Australia required inpatient rehabilitation. Children received high-quality inpatient rehabilitation care across both hospital settings, with the application of validated outcome measures and provision of rehabilitation care plans. Areas for improvement included greater involvement of families in the rehabilitation process, particularly with respect to the provision of regular family meetings to facilitate engagement. Conclusion: Although most children with stroke received high-quality care when compared against clinical practice guidelines, the findings highlight the importance of ongoing evaluation and continuous improvement in service provision, and the benefits of benchmarking the quality of current service provision against best practice treatment approaches recommended by consensus-based guidelines.
- Open Access
- 12 July 2022
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 53 (11) , 4990-5000
Development and initial validation of a multivariable predictive Early Adversity Scale for Schizophrenia (EAS-Sz) using register data to quantify environmental risk for adult schizophrenia diagnosis after childhood exposure to adversity
Background: Additional to a child's genetic inheritance, environmental exposures are associated with schizophrenia. Many are broadly described as childhood adversity; modelling the combined impact of these is complex. We aimed to develop and validate a scale on childhood adversity, independent of genetic and other environmental liabilities, for use in schizophrenia risk analysis models, using data from cross-linked electronic health and social services registers.Method: A cohort of N = 428 970 Western Australian children born 1980–2001 was partitioned into three samples: scale development sample (N = 171 588), and two scale validation samples (each N = 128 691). Measures of adversity were defined before a child's 10th birthday from five domains: discontinuity in parenting, family functioning, family structure, area-level socioeconomic/demographic environment and family-level sociodemographic status. Using Cox proportional hazards modelling of follow-up time from 10th birthday to schizophrenia diagnosis or censorship, weighted combinations of measures were firstly developed into scales for each domain, then combined into a final global scale. Discrimination and calibration performance were validated using Harrell's C and graphical assessment respectively.Results: A weighted combination of 42 measures of childhood adversity was derived from the development sample. Independent application to identical measures in validation samples produced Harrell's Concordance statistics of 0.656 and 0.624. Average predicted time to diagnosis curves corresponded with 95% CI limits of observed Kaplan–Meier curves in five prognostic categories.Conclusions: Our Early Adversity Scale for Schizophrenia (EAS-Sz), the first using routinely collected register data, predicts schizophrenia diagnosis above chance, and has potential to help untangle contributions of genetic and environmental liability to schizophrenia risk.
- 12 July 2022
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 53 (11) , 4990-5000
Open AccessDevelopment and initial validation of a multivariable predictive Early Adversity Scale for Schizophrenia (EAS-Sz) using register data to quantify environmental risk for adult schizophrenia diagnosis after childhood exposure to adversity
Background: Additional to a child's genetic inheritance, environmental exposures are associated with schizophrenia. Many are broadly described as childhood adversity; modelling the combined impact of these is complex. We aimed to develop and validate a scale on childhood adversity, independent of genetic and other environmental liabilities, for use in schizophrenia risk analysis models, using data from cross-linked electronic health and social services registers.Method: A cohort of N = 428 970 Western Australian children born 1980–2001 was partitioned into three samples: scale development sample (N = 171 588), and two scale validation samples (each N = 128 691). Measures of adversity were defined before a child's 10th birthday from five domains: discontinuity in parenting, family functioning, family structure, area-level socioeconomic/demographic environment and family-level sociodemographic status. Using Cox proportional hazards modelling of follow-up time from 10th birthday to schizophrenia diagnosis or censorship, weighted combinations of measures were firstly developed into scales for each domain, then combined into a final global scale. Discrimination and calibration performance were validated using Harrell's C and graphical assessment respectively.Results: A weighted combination of 42 measures of childhood adversity was derived from the development sample. Independent application to identical measures in validation samples produced Harrell's Concordance statistics of 0.656 and 0.624. Average predicted time to diagnosis curves corresponded with 95% CI limits of observed Kaplan–Meier curves in five prognostic categories.Conclusions: Our Early Adversity Scale for Schizophrenia (EAS-Sz), the first using routinely collected register data, predicts schizophrenia diagnosis above chance, and has potential to help untangle contributions of genetic and environmental liability to schizophrenia risk.
- 12 September 2020
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 55 (7) , 711-728
Mental health recovery and physical health outcomes in psychotic illness: Longitudinal data from the Western Australian survey of high impact psychosis catchments
Objective: There is a dearth of longitudinal data on outcomes in prevalent cases of psychotic illness across a range of ages and levels of chronicity. Our aim was to describe changes over time in mental and physical health outcomes, as well as patterns of service utilisation that may have influenced outcomes, in a representative prevalence sample of 641 Western Australians with a psychotic illness who, at Wave 1, were part of the National Survey of High Impact Psychosis. Methods: In Wave 1 (2010, 2012), a two-phase design was employed to ensure representativeness: Phase 1 psychosis screening took place in public mental health and non-government organisation services, while, in Phase 2, a randomised sample was interviewed. In Wave 2, 380/641 (59%) of participants were re-interviewed, with interviews staggered between 2013 and 2016 (follow-up time: 2.3–5.6 years). Data collection covered mental and physical health, functioning, cognition, social circumstances and service utilisation. Mental health outcomes were categorised as symptomatic, functional and personal recovery. Physical health outcomes covered metabolic syndrome and its component criteria. Results: In mental health, there were encouraging improvements in symptom profiles, variable change in functional recovery and some positive findings for personal recovery, but not quality of life. Participants ranked physical health second among challenges. Metabolic syndrome had increased significantly. While treatment for underlying cardiovascular risk conditions had improved, rates of intervention were still very low. More people were accessing general practices and more frequently, but there were sharp and significant declines in access to community rehabilitation, psychosocial interventions and case management. Conclusion: Although we observed some positive outcomes over time, the sharp decline in access to evidence-based interventions such as community rehabilitation, psychosocial interventions and case management is of great concern and augurs poorly for recovery-oriented practice. Changes in service utilisation appear to have influenced the patterns found.
- 12 September 2020
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 55 (7) , 711-728
Mental health recovery and physical health outcomes in psychotic illness: Longitudinal data from the Western Australian survey of high impact psychosis catchments
Objective: There is a dearth of longitudinal data on outcomes in prevalent cases of psychotic illness across a range of ages and levels of chronicity. Our aim was to describe changes over time in mental and physical health outcomes, as well as patterns of service utilisation that may have influenced outcomes, in a representative prevalence sample of 641 Western Australians with a psychotic illness who, at Wave 1, were part of the National Survey of High Impact Psychosis. Methods: In Wave 1 (2010, 2012), a two-phase design was employed to ensure representativeness: Phase 1 psychosis screening took place in public mental health and non-government organisation services, while, in Phase 2, a randomised sample was interviewed. In Wave 2, 380/641 (59%) of participants were re-interviewed, with interviews staggered between 2013 and 2016 (follow-up time: 2.3–5.6 years). Data collection covered mental and physical health, functioning, cognition, social circumstances and service utilisation. Mental health outcomes were categorised as symptomatic, functional and personal recovery. Physical health outcomes covered metabolic syndrome and its component criteria. Results: In mental health, there were encouraging improvements in symptom profiles, variable change in functional recovery and some positive findings for personal recovery, but not quality of life. Participants ranked physical health second among challenges. Metabolic syndrome had increased significantly. While treatment for underlying cardiovascular risk conditions had improved, rates of intervention were still very low. More people were accessing general practices and more frequently, but there were sharp and significant declines in access to community rehabilitation, psychosocial interventions and case management. Conclusion: Although we observed some positive outcomes over time, the sharp decline in access to evidence-based interventions such as community rehabilitation, psychosocial interventions and case management is of great concern and augurs poorly for recovery-oriented practice. Changes in service utilisation appear to have influenced the patterns found.
- 1 April 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 218, 180-187
Parsing components of risk of premature mortality in the children of mothers with severe mental illness
- 1 April 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 218, 180-187
Parsing components of risk of premature mortality in the children of mothers with severe mental illness
- 19 July 2019
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 55 (4) , 517-525
Impact of substance use and other risk factor exposures on conviction rates by people with a psychotic illness and other mental disorders
Purpose To examine the impact of substance use and other risk factors on conviction rates in people with a psychotic illness (PI) and other mental disorders (OMD) compared to those with no mental illness (NMI). Methods This research is part of a longitudinal record-linked whole-population study of 467,945 children born in Western Australia (WA) between 1980 and 2001. This cohort was identified through linkages between the WA psychiatric case register, WA corrective services data and other state-wide registers. We assessed 184,147 individuals born during 1983–1991 to explore the impact of exposure to a variety of risk factors on conviction rates. Results People with PI and OMD had higher conviction rates than those with NMI, with unadjusted incidence rate ratios (IRR) of 3.98 (95% CI 3.67–4.32) for PI and 3.18 (95% CI 3.03–3.34) for OMD. Adjusting for substance use reduced the rates by 60% in PI and 30% in OMD: IRRs 1.59 (95% CI 1.45–1.74) and 2.24 (2.12–2.37), respectively. Minimal change was seen when adjusting for other potential risk factors (including socio-demographics, victimisation and parental offending), with adjusted IRRs 1.58 (95% CI 1.43–1.74) for PI and 1.90 (95% CI 1.80–2.02) for OMD. Conclusions Our analysis shows people with a mental illness have higher rates of conviction than those with NMI. Substance use has a major impact on this rate. Results suggest the need for a greater investment in programs addressing the issue of comorbid substance use with a view to reduce the rate of convictions in this population.
- 19 July 2019
- Published by Springer Nature in Social Psychiatry and Psychiatric Epidemiology
- Vol. 55 (4) , 517-525
Impact of substance use and other risk factor exposures on conviction rates by people with a psychotic illness and other mental disorders
Purpose To examine the impact of substance use and other risk factors on conviction rates in people with a psychotic illness (PI) and other mental disorders (OMD) compared to those with no mental illness (NMI). Methods This research is part of a longitudinal record-linked whole-population study of 467,945 children born in Western Australia (WA) between 1980 and 2001. This cohort was identified through linkages between the WA psychiatric case register, WA corrective services data and other state-wide registers. We assessed 184,147 individuals born during 1983–1991 to explore the impact of exposure to a variety of risk factors on conviction rates. Results People with PI and OMD had higher conviction rates than those with NMI, with unadjusted incidence rate ratios (IRR) of 3.98 (95% CI 3.67–4.32) for PI and 3.18 (95% CI 3.03–3.34) for OMD. Adjusting for substance use reduced the rates by 60% in PI and 30% in OMD: IRRs 1.59 (95% CI 1.45–1.74) and 2.24 (2.12–2.37), respectively. Minimal change was seen when adjusting for other potential risk factors (including socio-demographics, victimisation and parental offending), with adjusted IRRs 1.58 (95% CI 1.43–1.74) for PI and 1.90 (95% CI 1.80–2.02) for OMD. Conclusions Our analysis shows people with a mental illness have higher rates of conviction than those with NMI. Substance use has a major impact on this rate. Results suggest the need for a greater investment in programs addressing the issue of comorbid substance use with a view to reduce the rate of convictions in this population.
- 1 July 2019
- Published by Elsevier in Schizophrenia Research
- Vol. 209, 272-273
Invited response to commentary. Small numbers are not predictive: Congenital blindness may or may not be protective for schizophrenia
- 1 July 2019
- Published by Elsevier in Schizophrenia Research
- Vol. 209, 272-273
Invited response to commentary. Small numbers are not predictive: Congenital blindness may or may not be protective for schizophrenia